Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gatenby, R. A.
Right arrow Articles by Gillies, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gatenby, R. A.
Right arrow Articles by Gillies, R. J.
[Cancer Research 66, 5216-5223, May 15, 2006]
© 2006 American Association for Cancer Research


Cell, Tumor, and Stem Cell Biology

Acid-Mediated Tumor Invasion: a Multidisciplinary Study

Robert A. Gatenby1,2, Edward T. Gawlinski4, Arthur F. Gmitro1,3, Brant Kaylor3 and Robert J. Gillies1

Departments of 1 Radiology, 2 Applied Mathematics, and 3 Optical Sciences, University of Arizona, Tucson Arizona; and 4 Department of Physics, Temple University, Philadelphia, Pennsylvania

Requests for reprints: Robert A. Gatenby, Department of Radiology, University Medical Center, 1501 North Campbell Avenue, Tucson, AZ 85718. Phone: 520-626-5725; Fax: 520-626-9981; E-mail: rgatenby{at}radiology.arizona.edu.

The acid-mediated tumor invasion hypothesis proposes altered glucose metabolism and increased glucose uptake, observed in the vast majority of clinical cancers by fluorodeoxyglucose-positron emission tomography, are critical for development of the invasive phenotype. In this model, increased acid production due to altered glucose metabolism serves as a key intermediate by producing H+ flow along concentration gradients into adjacent normal tissue. This chronic exposure of peritumoral normal tissue to an acidic microenvironment produces toxicity by: (a) normal cell death caused by the collapse of the transmembrane H+ gradient inducing necrosis or apoptosis and (b) extracellular matrix degradation through the release of cathepsin B and other proteolytic enzymes. Tumor cells evolve resistance to acid-induced toxicity during carcinogenesis, allowing them to survive and proliferate in low pH microenvironments. This permits them to invade the damaged adjacent normal tissue despite the acid gradients. Here, we describe theoretical and empirical evidence for acid-mediated invasion. In silico simulations using mathematical models provide testable predictions concerning the morphology and cellular and extracellular dynamics at the tumor-host interface. In vivo experiments confirm the presence of peritumoral acid gradients as well as cellular toxicity and extracellular matrix degradation in the normal tissue exposed to the acidic microenvironment. The acid-mediated tumor invasion model provides a simple mechanism linking altered glucose metabolism with the ability of tumor cells to form invasive cancers. (Cancer Res 2006; 66(10): 5216-23)




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. Swietach, S. Wigfield, P. Cobden, C. T. Supuran, A. L. Harris, and R. D. Vaughan-Jones
Tumor-associated Carbonic Anhydrase 9 Spatially Coordinates Intracellular pH in Three-dimensional Multicellular Growths
J. Biol. Chem., July 18, 2008; 283(29): 20473 - 20483.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Jo, Y. Jia, K. K. Subramanian, H. Hattori, and H. R. Luo
Cancer Cell-Derived Clusterin Modulates the Phosphatidylinositol 3'-Kinase-Akt Pathway through Attenuation of Insulin-Like Growth Factor 1 during Serum Deprivation
Mol. Cell. Biol., July 1, 2008; 28(13): 4285 - 4299.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
R. J. Gillies, I. Robey, and R. A. Gatenby
Causes and Consequences of Increased Glucose Metabolism of Cancers
J. Nucl. Med., June 1, 2008; 49(Suppl_2): 24S - 42S.
[Abstract] [Full Text] [PDF]


Home page
aacredbookHome page
L. A Kingsley, P. G J Fournier, J. M Chirgwin, and T. A Guise
Molecular Biology of Bone Metastasis
Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 443 - 457.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
K. C. Rice and K. W. Bayles
Molecular Control of Bacterial Death and Lysis
Microbiol. Mol. Biol. Rev., March 1, 2008; 72(1): 85 - 109.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Glunde, T. Shah, P. T. Winnard Jr., V. Raman, T. Takagi, F. Vesuna, D. Artemov, and Z. M. Bhujwalla
Hypoxia Regulates Choline Kinase Expression through Hypoxia-Inducible Factor-1{alpha} Signaling in a Human Prostate Cancer Model
Cancer Res., January 1, 2008; 68(1): 172 - 180.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
L. A. Kingsley, P. G.J. Fournier, J. M. Chirgwin, and T. A. Guise
Molecular Biology of Bone Metastasis
Mol. Cancer Ther., October 1, 2007; 6(10): 2609 - 2617.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Provent, M. Benito, B. Hiba, R. Farion, P. Lopez-Larrubia, P. Ballesteros, C. Remy, C. Segebarth, S. Cerdan, J. A. Coles, et al.
Serial In vivo Spectroscopic Nuclear Magnetic Resonance Imaging of Lactate and Extracellular pH in Rat Gliomas Shows Redistribution of Protons Away from Sites of Glycolysis
Cancer Res., August 15, 2007; 67(16): 7638 - 7645.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Yang, H. Chen, I. R. Vlahov, J.-X. Cheng, and P. S. Low
Characterization of the pH of Folate Receptor-Containing Endosomes and the Rate of Hydrolysis of Internalized Acid-Labile Folate-Drug Conjugates
J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 462 - 468.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.